Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma

Wim Kruit; S Suciu; B Dreno; L Mortier; C Robert; V Chiarion-Sileni; M Maio; A Testori; T Dorval; JJ Grob; JC Becker; A Spatz; Lex Eggermont; J Louahed; FF Lehmann; VG Brichard; U Keilholz

doi:10.1200/JCO.2012.43.7111

Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma

Wim Kruit, S Suciu, B Dreno, L Mortier, C Robert, V Chiarion-Sileni, M Maio, A Testori, T Dorval, JJ Grob, JC Becker, A Spatz, Lex Eggermont, J Louahed, FF Lehmann, VG Brichard, U Keilholz

Research output: Contribution to journal › Article › Academic › peer-review

188 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2413-2420
Number of pages	8
Journal	Journal of Clinical Oncology
Volume	31
Issue number	19
DOIs	https://doi.org/10.1200/JCO.2012.43.7111
Publication status	Published - 2013

Research programs

EMC MM-03-47-11
EMC MM-03-86-08

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JCO.2012.43.7111

http://hdl.handle.net/1765/58045

Cite this

Kruit, W., Suciu, S., Dreno, B., Mortier, L., Robert, C., Chiarion-Sileni, V., Maio, M., Testori, A., Dorval, T., Grob, JJ., Becker, JC., Spatz, A., Eggermont, L., Louahed, J., Lehmann, FF., Brichard, VG., & Keilholz, U. (2013). Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma. Journal of Clinical Oncology, 31(19), 2413-2420. https://doi.org/10.1200/JCO.2012.43.7111

@article{097517f87adc49eaa273ec67a1a85ff4,

title = "Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma",

author = "Wim Kruit and S Suciu and B Dreno and L Mortier and C Robert and V Chiarion-Sileni and M Maio and A Testori and T Dorval and JJ Grob and JC Becker and A Spatz and Lex Eggermont and J Louahed and FF Lehmann and VG Brichard and U Keilholz",

year = "2013",

doi = "10.1200/JCO.2012.43.7111",

language = "Undefined/Unknown",

volume = "31",

pages = "2413--2420",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins",

number = "19",

}

Kruit, W, Suciu, S, Dreno, B, Mortier, L, Robert, C, Chiarion-Sileni, V, Maio, M, Testori, A, Dorval, T, Grob, JJ, Becker, JC, Spatz, A, Eggermont, L, Louahed, J, Lehmann, FF, Brichard, VG & Keilholz, U 2013, 'Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma', Journal of Clinical Oncology, vol. 31, no. 19, pp. 2413-2420. https://doi.org/10.1200/JCO.2012.43.7111

Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma. / Kruit, Wim; Suciu, S; Dreno, B et al.
In: Journal of Clinical Oncology, Vol. 31, No. 19, 2013, p. 2413-2420.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma

AU - Kruit, Wim

AU - Suciu, S

AU - Dreno, B

AU - Mortier, L

AU - Robert, C

AU - Chiarion-Sileni, V

AU - Maio, M

AU - Testori, A

AU - Dorval, T

AU - Grob, JJ

AU - Becker, JC

AU - Spatz, A

AU - Eggermont, Lex

AU - Louahed, J

AU - Lehmann, FF

AU - Brichard, VG

AU - Keilholz, U

PY - 2013

Y1 - 2013

U2 - 10.1200/JCO.2012.43.7111

DO - 10.1200/JCO.2012.43.7111

M3 - Article

C2 - 23715572

SN - 0732-183X

VL - 31

SP - 2413

EP - 2420

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 19

ER -

Kruit W, Suciu S, Dreno B, Mortier L, Robert C, Chiarion-Sileni V et al. Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma. Journal of Clinical Oncology. 2013;31(19):2413-2420. doi: 10.1200/JCO.2012.43.7111